CD4 T cell counts are an essential part of monitoring the progression and treatment of HIV patients; a service that is unavailable in most resource poor regions in the world. Canadian and African researchers are partnering to test low cost point-of-care HIV monitoring devices, which are purpose-built to be rugged, reliable and cost effective.